NORTHWEST BIOTHERAPEUTICS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $26.70 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-14
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $26.70M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $38.71M.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $47.06M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $60.81M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2026-06-30 | $26.70M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $38.71M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $47.06M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $60.81M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $48.26M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $47.15M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $46.16M 10-K · filed 2026-04-15 |
| 2024-09-30 | $32.52M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $25.53M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $26.63M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $23.39M 10-K · filed 2026-04-15 |
| 2023-09-30 | $19.54M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $10.01M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $10.48M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $90.71M 10-K · filed 2025-03-31 |
| 2022-09-30 | $82.58M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $74.84M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $107.90M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $116.00M 10-K · filed 2024-03-05 |
| 2021-09-30 | $290.92M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $341.46M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $350.42M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $365.75M 10-K · filed 2023-02-28 |
| 2019-12-31 | $27.47M 10-K · filed 2022-03-01 |
| 2018-12-31 | $30.35M 10-K · filed 2021-03-31 |
| 2018-09-30 | $32.10M 10-Q · filed 2018-11-16 |
| 2018-06-30 | $56.74M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $59.85M 10-Q · filed 2018-05-16 |
| 2017-12-31 | $46.09M 10-K · filed 2020-03-16 |
| 2017-09-30 | $17.69M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $13.70M 10-Q · filed 2017-08-21 |
| 2017-03-31 | $14.10M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $10.06M 10-K · filed 2019-04-02 |
| 2015-12-31 | $27.98M 10-K · filed 2018-04-17 |
| 2014-12-31 | $44.74M 10-K · filed 2017-04-17 |
| 2014-09-30 | $29.83M 10-Q · filed 2014-11-19 |
| 2014-06-30 | $31.08M 10-Q · filed 2014-11-19 |
| 2014-03-31 | $33.62M 10-Q · filed 2014-11-19 |
| 2013-12-31 | $8.69M 10-Q · filed 2014-11-19 |